AURX
Nuo Therapeutics, Inc.
$1.04
0.00%
No data for this timeframe.
Vol
SEC Reports1
Exchange OTC·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001091596·Prev Close $1.04
Recent Activity
Jun 5, 2026
Insider
JORDEN DAVID EMERSON was granted 13,245 shares
CEO/CFO @ $1.10 ($14.5K)
May 29, 2026
Insider
Pittman Scott M. was granted 7,333 shares
Director @ $1.50 ($11.0K)
May 29, 2026
Insider
Pittman Scott M. was granted 17,500 shares
Director @ $1.50 ($26.3K)
May 14, 2026
SEC
Nuo Therapeutics reported Q1 2026 total revenue of $1.3M, up 169% YoY from $484K, driven by Aurix product sales growth o
8-K — Impact 6/10
Mar 30, 2026
earnings_calendar
AURX Q4 2025 Earnings Scheduled — 2026-03-30
Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$3.00 (Dec 2025)
Current $1.15
Low $3.00
Median $3.00
High $3.00
1 analysts
$3.00
$3.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 16, 2025 | Roth Capital | INITIATE | Buy |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 5, 2026 | JORDEN DAVID | A | $14.5K |
| May 29, 2026 | Pittman Scott | A | $11.0K |
| May 29, 2026 | Pittman Scott | A | $26.3K |
| May 29, 2026 | Pittman Scott | D | $11.3K |
| May 29, 2026 | Pittman Scott | D | $55.1K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
2 unique insiders with 9 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | JORDEN DAVID EMERSON | CEO/CFO | AWARD | 13,245 | $1.10 | $14.5K |
| May 29, 2026 | Pittman Scott M. | Director | AWARD | 7,333 | $1.50 | $11.0K |
| May 29, 2026 | Pittman Scott M. | Director | AWARD | 17,500 | $1.50 | $26.3K |
| May 29, 2026 | Pittman Scott M. | Director | D | 7,516 | $1.50 | $11.3K |
| May 29, 2026 | Pittman Scott M. | Director | D | 36,750 | $1.50 | $55.1K |
| May 29, 2026 | Pittman Scott M. | Director | AWARD | 17,450 | $1.50 | $26.2K |
| Jan 23, 2026 | Pittman Scott M. | Director | AWARD | 30,050 | $1.50 | $45.1K |
| Jan 23, 2026 | Pittman Scott M. | Director | AWARD | 36,750 | $1.50 | $55.1K |
| Jan 23, 2026 | Pittman Scott M. | Director | AWARD | 7,516 | $1.50 | $11.3K |
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$3.00 mean target (Dec 2025)
$3.00 Low
$3.00 High
| Metric | Value |
|---|---|
| Current Price | $1.15 |
| Target Low | $3.00 |
| Target Mean | $3.00 |
| Target Median | $3.00 |
| Target High | $3.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 16, 2025 | Roth Capital | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Mar 30, 2026
earnings_calendar
AURX Q4 2025 Earnings Scheduled — 2026-03-30